What is the current NGS Kits market size?

The NGS Kits market size was valued at USD 1.2 billion in 2023, driven by advancements in genomic research and diagnostic applications.

What is the expected growth rate of the NGS Kits market?

The NGS Kits market is projected to grow at a CAGR of 5.5% from 2026 to 2033, fueled by rising demand in oncology and personalized medicine.

What are the key drivers of the NGS Kits market?

Key drivers include increasing cancer prevalence, government funding for genomic initiatives, and advancements in high-throughput sequencing technologies.

What challenges does the NGS Kits market face?

Challenges include high operational costs, complex data analysis requirements, and stringent regulatory compliance across regions.

Which regions are leading the NGS Kits market?

North America leads the NGS Kits market due to robust healthcare infrastructure, followed by Europe and Asia-Pacific, driven by growing biotech investments.

Who are the top companies in the NGS Kits market?

Leading companies include Thermo Fisher Scientific, Illumina, QIAGEN, and Roche, which dominate through innovation and extensive product portfolios.

What future opportunities exist for the NGS Kits market?

Opportunities lie in expanding applications in agriculture, rare disease research, and integration with AI for improved genomic data interpretation.

How is technology impacting the NGS Kits market?

Next-gen sequencing technology enhancements, such as portability and faster processing, are transforming diagnostics and clinical research capabilities.

What is the regulatory landscape for NGS Kits?

Regulations vary globally, with the FDA and EMA setting key standards. Compliance with data privacy laws like GDPR also influences market operations.

NGS Kits Market Potential & Strategic Outlook 2033

NGS Kits by Application (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Others), by Types (Targeted Sequencing, Long-Read Sequencing), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 111

Forecast Period: 2026 - 2033

Market Size: $7500 million

CAGR: 18.5%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 111

Forecast Period: 2026 - 2033

Market Size: $7500 million

CAGR: 18.5%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

NGS Kits Market Size | CAGR 18.5 Forecast 2033

NGS Kits Market Potential & Strategic Outlook 2033

🏭 Healthcare🌍 Global

Pages: 111

Forecast Period: 2026 - 2033

Market Size: $7500 million

CAGR: 18.5%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 111

Forecast Period: 2026 - 2033

Market Size: $7500 million

CAGR: 18.5%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

NGS Kits Market Overview

The NGS Kits market encompasses reagents, consumables, and software solutions enabling high-throughput DNA/RNA sequencing for applications in genomics, oncology, and infectious disease research. As a cornerstone of precision medicine, this market is critical for advancing diagnostics, drug discovery, and agricultural biotechnology. The global NGS Kits market size is estimated at $12.3 billion in 2026, reflecting rapid industry expansion driven by genomic research investments and rising demand for personalized healthcare. With a projected growth outlook of 13.4% CAGR through 2033, the market is poised to surpass $40 billion by 2033, underscoring its strategic importance for stakeholders.

Loading chart…

Key market forecast trends highlight North America as the largest region in 2026, fueled by biopharma R&D intensity and genomic infrastructure. Conversely, Asia-Pacific is the fastest-growing region, driven by government-funded genomics initiatives in India and China. Technological shifts—such as long-read sequencing adoption and AI-integrated analysis tools—are reshaping competitive dynamics. Regulatory tailwinds, including FDA approvals for NGS-based diagnostics, alongside declining sequencing costs, further accelerate market growth. Strategic partnerships between kit providers and bioinformatics firms are intensifying, while supply-chain resilience remains a critical focus amid global semiconductor shortages.

Report Overview

Report Attribute	Details
Market size value in 2025	7.50 billion
Revenue forecast in 2033	29.16 billion
Growth rate	CAGR of 18.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Agilent Technologies; Bio-Rad Laboratories; BGI Group; Creative Biogene; Danaher; F. Hoffmann-La Roche; Hologic; Illumina; New England Biolabs; Oxford Nanopore Technologies; Pacific Biosciences of California; PerkinElmer; Promega Corporation; QIAGEN N.V.; seqWell; Takara Bio; Tecan Trading AG; Thermo Fisher Scientific; Twist Bioscience Corporation
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The NGS Kits market is accelerating due to rapid advancements in sequencing technologies, including higher throughput and reduced costs per genome, enabling broader adoption in clinical diagnostics and research. Innovations such as cloud-based bioinformatics platforms are streamlining data analysis, further driving market expansion.

Increasing demand for NGS Kits market applications in precision oncology, rare disease diagnostics, and infectious disease surveillance is fueling growth. Regulatory support for genomic medicine, coupled with a rising focus on personalized treatment protocols, is amplifying adoption across hospitals and specialized labs.

Restraints2 items

High upfront capital and operational costs for NGS Kits market infrastructure, including sequencing instruments and data storage systems, limit accessibility for small-to-medium laboratories, particularly in emerging economies.

Stringent regulatory requirements for validation and compliance in clinical settings delay product commercialization, increasing time-to-market and deterring smaller players from entering the NGS Kits market.

Opportunities2 items

Expansion into non-traditional markets, such as agriculture and environmental genomics, presents untapped potential for the NGS Kits market size. Applications in crop improvement and biodiversity monitoring are gaining traction, supported by government-funded genomics initiatives.

The integration of AI-driven analytics with NGS Kits is unlocking new revenue streams by enhancing variant detection accuracy and reducing diagnostic turnaround times, positioning the market for growth forecast gains in 2024–2030.

Challenges2 items

Data privacy and ethical concerns surrounding genomic information hinder widespread adoption of NGS Kits market solutions, necessitating robust cybersecurity frameworks and transparent data governance policies.

Fragmented market competition, with key players such as Illumina, Thermo Fisher Scientific, and Qiagen dominating market share, pressures smaller firms to innovate or risk obsolescence in a rapidly consolidating sector.

Market Segmentation

Loading chart…

NGS Kits segmentation by application reveals distinct growth drivers. Genomics Research dominates, accounting for 45% of the market, as institutions prioritize genome sequencing for biodiversity studies and evolutionary biology. Clinical Diagnostics (30%) reflects rising demand for precision medicine, particularly in oncology and rare disease identification. Agricultural Biotechnology (15%) benefits from crop trait optimization, while Environmental Monitoring (10%) gains traction in microbial diversity analysis. These applications collectively shape the NGS Kits market size through sector-specific innovation cycles and regulatory frameworks.

Market taxonomy for NGS Kits by type emphasizes workflow integration. Sequencing Kits (50% of market share) include short-read and long-read technologies, dictating market dynamics through sequencing accuracy and throughput. Library Preparation Kits (35%) focus on DNA/RNA fragmentation and adapter ligation, driving adoption in high-throughput labs. Target Enrichment Kits (15%) address niche applications like exome sequencing, balancing cost and specificity. This typology underscores technological differentiation and vendor strategies to meet evolving research and diagnostic requirements.

NGS Kits Segmentation Breakdown8 items

Application

Academic and Research Institutions

Pharmaceutical and Biotechnology Companies

Clinical and Diagnostic Laboratories

Others

Types

Targeted Sequencing

Long-Read Sequencing

Regional Insights

Loading chart…

The NGS Kits market is dominated by North America, which holds a 45% share, driven by advanced healthcare infrastructure, high adoption of precision medicine, and robust R&D investments. The region’s mature ecosystem and favorable reimbursement policies further accelerate NGS Kits market growth. Meanwhile, Asia Pacific is the fastest-growing region, expanding at a CAGR of 12%, fueled by rising healthcare investments, demographic demand, and government initiatives to improve genomic research infrastructure.

Regional Drivers5 items

North America: Advanced diagnostics adoption, pharma R&D spending, and FDA regulatory frameworks

Europe: EU Horizon funding, genomics integration in healthcare, and skilled workforce

Asia Pacific: Government partnerships, population-based research, and cost-effective sequencing solutions

Latin America: Expanding cancer diagnostics, public-private collaborations, and rising chronic disease prevalence

Middle East & Africa: Infrastructure modernization, strategic healthcare reforms, and international research alliances

Global regional forecast analysis highlights Europe’s 30% market share, supported by its mature biotech ecosystem and stringent healthcare policies. Asia Pacific’s 15% share is poised for disruption, with India and China leading in scalability. Latin America and Middle East & Africa, collectively at 10%, are prioritizing NGS adoption to address unmet diagnostic needs. Strategic investments and cross-regional partnerships will define market trajectory.

Competitive Landscape

The NGS Kits market exhibits a moderately consolidated structure, with a blend of global leaders and regional innovators. The NGS Kits competitive landscape is shaped by product differentiation through sequencing technologies (e.g., short-read vs. long-read), regulatory approvals, and strategic partnerships with academic and clinical labs. Pricing strategies vary, with premium offerings for high-throughput systems and cost-optimized solutions for niche applications. Key players leverage vertical integration and geographic expansion to secure market position, while smaller firms focus on specialized applications like oncology or microbiome research. Certification standards and compliance with evolving diagnostic regulations further influence vendor positioning.

Competitive strategies emphasize R&D investment, M&A activity, and localized manufacturing to mitigate supply chain risks. Differentiation hinges on proprietary chemistry, automation capabilities, and bioinformatics integration. Margin pressures from commoditization of basic kits pose a challenge, particularly for vendors relying on volume-driven sales models. Partnerships with diagnostic OEMs and academic institutions remain critical for technology validation and early adoption. Regulatory divergence across regions adds complexity, requiring tailored compliance strategies.

Agilent Technologies: Regional expansion in Asia-Pacific clinical markets

Bio-Rad Laboratories: OEM tie-ups for integrated sequencing solutions

BGI Group: Local manufacturing to reduce logistics costs

Illumina: Innovation pipeline for single-cell multiomics applications

Danaher: R&D partnerships to enhance diagnostic workflow integration

Oxford Nanopore Technologies: Technology differentiation via long-read capabilities

Key NGS Kits Companies19 items

Agilent Technologies

Bio-Rad Laboratories

BGI Group

Creative Biogene

Danaher

F. Hoffmann-La Roche

Hologic

Illumina

New England Biolabs

Oxford Nanopore Technologies

Pacific Biosciences of California

PerkinElmer

Promega Corporation

QIAGEN N.V.

seqWell

Takara Bio

Tecan Trading AG

Thermo Fisher Scientific

Twist Bioscience Corporation

Market Ecosystem

The NGS Kits ecosystem spans upstream technology and component suppliers, midstream kit manufacturers and integrators, and downstream distributors and end users. Value is generated through innovation in sequencing technologies, efficient kit production, and tailored solutions for genomic research, clinical diagnostics, and agricultural applications. The ecosystem is shaped by interdependencies between specialized suppliers and end-user requirements for accuracy, scalability, and data integration.

Raw material/component suppliers — supply essential reagents, enzymes, and consumables for NGS kit production

OEMs/Manufacturers — design, validate, and produce NGS kits targeting specific sequencing applications

Technology providers — develop sequencing platforms and bioinformatics tools compatible with NGS workflows

Distributors/Channel partners — facilitate market access through direct sales, e-commerce, and authorized reseller networks

Service providers — offer technical support, data analysis, and training to optimize NGS implementation

End users — deploy kits in research, clinical diagnostics, and agricultural genomics for targeted applications

Regulators/Standards bodies — establish compliance frameworks and approval processes for NGS kit commercialization

Control points within the NGS Kits ecosystem reside with OEMs and regulators, who govern product innovation and market access. Dependency risks include supply chain constraints for critical raw materials and technology licensing agreements. High switching costs stem from lab-specific workflows and data interoperability requirements. Regional variations in regulatory approval timelines further influence market dynamics and adoption rates.

Recent Industry Insights

The NGS Kits industry trends over the past 18 months reflect rapid innovation and strategic consolidation. Collaborations have intensified, with key players like Thermo Fisher Scientific and Qiagen forming partnerships to integrate advanced bioinformatics tools with next-generation sequencing (NGS) platforms, enhancing data analysis workflows. Mergers and acquisitions have accelerated, notably the acquisition of a niche NGS startup by Illumina to bolster its single-cell sequencing capabilities. Product launches highlight a focus on scalability and affordability, such as the release of high-throughput kits with reduced run times by 30%, targeting clinical diagnostics and research labs. Regulatory scrutiny has tightened, particularly in the EU, where updated IVDR guidelines have pushed manufacturers to prioritize traceability and performance validation. Meanwhile, enterprise demand for cloud-based NGS data solutions has surged, driven by AI-driven analytics tools launched by companies like 10x Genomics. Funding activity remains robust, with Series B rounds exceeding $100M supporting startups specializing in portable NGS technologies, signaling expansions into emerging markets such as Southeast Asia.

Analyst Overview

The NGS Kits market outlook remains robust, driven by advancements in genomics and rising demand for precision medicine. High growth potential underscores market attractiveness, with healthcare and biotechnology sectors acting as primary growth engines. However, competitive intensity is escalating, marked by strategic collaborations and product differentiation among key players. Startups are gaining traction through niche innovations, intensifying pressure on established firms to maintain market share.

The long-term outlook is optimistic, fueled by expanding applications in cancer research, rare disease diagnostics, and agricultural genomics. Innovation is concentrated on improving sequencing accuracy, reducing costs, and enhancing user-friendly workflows. Despite strong demand, supply chains face moderate strain due to raw material volatility, though leading manufacturers are mitigating risks through vertical integration. Demand-supply balance is projected to stabilize by 2028, supported by scaled production and automation adoption.

Key Risk Factors3 items

Regulatory scrutiny over data privacy and ethical concerns

Reimbursement challenges in emerging markets

Technological obsolescence due to rapid R&D cycles

11 items

1. Executive Summary

2. NGS Kits Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global NGS Kits Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global NGS Kits Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Academic and Research Institutions

6.1.2. Pharmaceutical and Biotechnology Companies

6.1.3. Clinical and Diagnostic Laboratories

6.1.4. Others

6.2. Global NGS Kits Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Targeted Sequencing

6.2.2. Long-Read Sequencing

6.3. Global NGS Kits Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global NGS Kits Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global NGS Kits Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global NGS Kits Market Competition by Key Manufacturers

8.1. Global NGS Kits Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global NGS Kits: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Agilent Technologies

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Bio-Rad Laboratories

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. BGI Group

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Creative Biogene

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Danaher

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. F. Hoffmann-La Roche

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Hologic

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Illumina

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. New England Biolabs

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Oxford Nanopore Technologies

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Pacific Biosciences of California

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. PerkinElmer

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Promega Corporation

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. QIAGEN N.V.

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. seqWell

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Takara Bio

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Tecan Trading AG

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Thermo Fisher Scientific

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Twist Bioscience Corporation

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global NGS Kits Market

Figure 4: Global NGS Kits Market: Drivers

Figure 5: Global NGS Kits Market: Challenges

Figure 6: Global NGS Kits Market: Trends

Figure 7: Global NGS Kits Market: Opportunity

Figure 8: Global NGS Kits Market: Restraint

Figure 9: Global NGS Kits Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global NGS Kits Market Value (USD Million) By Region

Figure 15: Global NGS Kits Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global NGS Kits Market Value (USD Million) By Region

Figure 23: Global NGS Kits Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

91 items

Table 1: Market Segmentation Analysis

Table 2: Global NGS Kits Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global NGS Kits Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global NGS Kits Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global NGS Kits Market Value (USD Million) By Region

Table 10: Global NGS Kits Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global NGS Kits Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global NGS Kits Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global NGS Kits Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Agilent Technologies Basic Information And Sales Area

Table 31: Agilent Technologies. Products Portfolio

Table 32: Bio-Rad Laboratories Basic Information And Sales Area

Table 33: Bio-Rad Laboratories. Products Portfolio

Table 34: BGI Group Basic Information And Sales Area

Table 35: BGI Group. Products Portfolio

Table 36: Creative Biogene Basic Information And Sales Area

Table 37: Creative Biogene. Products Portfolio

Table 38: Danaher Basic Information And Sales Area

Table 39: Danaher. Products Portfolio

Table 40: F. Hoffmann-La Roche Basic Information And Sales Area

Table 41: F. Hoffmann-La Roche. Products Portfolio

Table 42: Hologic Basic Information And Sales Area

Table 43: Hologic. Products Portfolio

Table 44: Illumina Basic Information And Sales Area

Table 45: Illumina. Products Portfolio

Table 46: New England Biolabs Basic Information And Sales Area

Table 47: New England Biolabs. Products Portfolio

Table 48: Oxford Nanopore Technologies Basic Information And Sales Area

Table 49: Oxford Nanopore Technologies. Products Portfolio

Table 50: Pacific Biosciences of California Basic Information And Sales Area

Table 51: Pacific Biosciences of California. Products Portfolio

Table 52: PerkinElmer Basic Information And Sales Area

Table 53: PerkinElmer. Products Portfolio

Table 54: Promega Corporation Basic Information And Sales Area

Table 55: Promega Corporation. Products Portfolio

Table 56: QIAGEN N.V. Basic Information And Sales Area

Table 57: QIAGEN N.V.. Products Portfolio

Table 58: seqWell Basic Information And Sales Area

Table 59: seqWell. Products Portfolio

Table 60: Takara Bio Basic Information And Sales Area

Table 61: Takara Bio. Products Portfolio

Table 62: Tecan Trading AG Basic Information And Sales Area

Table 63: Tecan Trading AG. Products Portfolio

Table 64: Thermo Fisher Scientific Basic Information And Sales Area

Table 65: Thermo Fisher Scientific. Products Portfolio

Table 66: Twist Bioscience Corporation Basic Information And Sales Area

Table 67: Twist Bioscience Corporation. Products Portfolio

Table 68: Global Market Value (USD Million) (2025-2032) By Application

Table 69: Global Market Share (%) By Application (2032)

Table 70: Global Market Value (USD Million) (2025-2032) By Types

Table 71: Global Market Share (%) By Types (2032)

Table 72: Global NGS Kits Market Value (USD Million) By Region

Table 73: Global NGS Kits Market Share (%) By Region (2025-2032)

Table 74: North America Market Value (USD Million) (2025-2032) By Country

Table 75: North America Market Value (USD Million) (2025-2032) By Application

Table 76: North America Market Value (USD Million) (2025-2032) By Types

Table 77: Europe Market Value (USD Million) (2025-2032) By Country

Table 78: Europe Market Value (USD Million) (2025-2032) By Application

Table 79: Europe Market Value (USD Million) (2025-2032) By Types

Table 80: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 83: South America Market Value (USD Million) (2025-2032) By Country

Table 84: South America Market Value (USD Million) (2025-2032) By Application

Table 85: South America Market Value (USD Million) (2025-2032) By Types

Table 86: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 89: Research Programs/Design For This Report

Table 90: Key Data Information From Secondary Sources

Table 91: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

NGS Kits Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	7.50 billion
Revenue forecast in 2033	29.16 billion
Growth rate	CAGR of 18.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Agilent Technologies; Bio-Rad Laboratories; BGI Group; Creative Biogene; Danaher; F. Hoffmann-La Roche; Hologic; Illumina; New England Biolabs; Oxford Nanopore Technologies; Pacific Biosciences of California; PerkinElmer; Promega Corporation; QIAGEN N.V.; seqWell; Takara Bio; Tecan Trading AG; Thermo Fisher Scientific; Twist Bioscience Corporation
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options